Nachum Shamir - 10 Nov 2026 Form 4 Insider Report for MediWound Ltd. (MDWD)

SEC form
4
Accepted by SEC
12 Nov 2026, 07:34:35 UTC
Prior SEC filing
01 Jul 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Nachum Shamir filed Form 4 for MediWound Ltd. (MDWD) on 12 Nov 2026.

Key facts

  • This page summarizes Nachum Shamir's Form 4 filing for MediWound Ltd. (MDWD).
  • 2 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2026, 07:34.

Change

  • Previous filing in this sequence was filed on 01 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001622164 Primary reporting owner

SHAMIR NACHUM

Relationship
Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDWD transaction

Ordinary Shares

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
+16,336
Change %
+29%
Price
$13.48*
Shares after
72,151
Date
10 Nov 2026
Ownership
Direct
Footnotes
F4
MDWD holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,200
Date
10 Nov 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDWD transaction Derivative

Series A Warrants

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-16,336
Change %
-100%
Price
Shares after
0
Date
10 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
16,336
Exercise price
$13.48
Footnotes
F4
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,571
Date
10 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
28,571
Exercise price
$12.50
Footnotes
F2
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,800
Date
10 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
11,800
Exercise price
$11.88
Footnotes
F2
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,570
Date
10 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
12,570
Exercise price
$12.73
Footnotes
F2
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,200
Date
10 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
9,200
Exercise price
$18.54
Footnotes
F2
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
10 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,000
Exercise price
$17.60
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

Footnote F2

There were no transactions affected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Footnote F3

The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

Footnote F4

On November 10, 2026, the Reporting Person exercised Series A Warrants to purchase 16,336 ordinary shares at an exercise price of $13.475 per share, paying the aggregate exercise price in cash. The Reporting Person did not sell any of the ordinary shares acquired upon the exercise. No separate price was paid for the Series A Warrants upon exercise. The exercise price is reported in column 2 and in Table I.

SEC remarks

Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .